InsiderClue
Insiders · Profile

Esposito Pamela

Director at Kymera Therapeutics · Chief Business Officer at Replimune. Filing since 31 Aug 2020. CIK 0001744425

KYMR Kymera Therapeutics, Inc. Director · 7 trades REPL Replimune Group, Inc. Chief Business Officer · 18 trades
Company
Date
Role
Action
Shares
Amount
Of holding
KYMR Kymera Therapeutics, Inc.
20 Mar 2026
Director
Sold on a plan
2,500
$197.88K
100%
KYMR Kymera Therapeutics, Inc.
20 Feb 2026
Director
Sold on a plan
2,500
$218.27K
100%
KYMR Kymera Therapeutics, Inc.
20 Jan 2026
Director
Sold on a plan
5,500
$373.52K
100%
KYMR Kymera Therapeutics, Inc.
17 Dec 2025
Director
Sold on a plan
27,563
$2.26M
100%
KYMR Kymera Therapeutics, Inc.
3 Jun 2025
Director
Sold on a plan
5,000
$245.19K
100%
KYMR Kymera Therapeutics, Inc.
2 Dec 2024
Director
Sold on a plan
2,500
$122.50K
100%
KYMR Kymera Therapeutics, Inc.
17 Sep 2024
Director
Sold on a plan
13,500
$651.77K
100%
REPL Replimune Group, Inc.
12 Sep 2023
Chief Business Officer
Sold on a plan
300
$6.00K
0.1%
REPL Replimune Group, Inc.
11 Sep 2023
Chief Business Officer
Sold on a plan
5,358
$107.21K
2.0%
REPL Replimune Group, Inc.
22 Aug 2023
Chief Business Officer
Sold on a plan
18,600
$372.19K
6.6%
REPL Replimune Group, Inc.
11 Aug 2023
Chief Business Officer
Sold on a plan
1,400
$28.00K
0.5%
REPL Replimune Group, Inc.
10 Jul 2023
Chief Business Officer
Sold on a plan
20,000
$431.54K
7.1%
REPL Replimune Group, Inc.
16 May 2023
Chief Business Officer
Sold at will
5,966
$107.69K
2.2%
REPL Replimune Group, Inc.
9 Dec 2022
Chief Business Officer
Sold, plan not stated
15,000
$375.45K
6.1%
REPL Replimune Group, Inc.
16 May 2022
Chief Business Officer
Sold, plan not stated
3,507
$51.17K
1.5%
REPL Replimune Group, Inc.
5 Aug 2021
Chief Business Officer
Sold, plan not stated
25,800
$905.32K
10.9%
REPL Replimune Group, Inc.
4 Aug 2021
Chief Business Officer
Sold, plan not stated
4,200
$147.00K
2.0%
REPL Replimune Group, Inc.
21 Jul 2021
Chief Business Officer
Sold, plan not stated
12,538
$415.89K
5.6%
REPL Replimune Group, Inc.
20 Jul 2021
Chief Business Officer
Sold, plan not stated
4,862
$160.69K
2.3%
REPL Replimune Group, Inc.
15 Jul 2021
Chief Business Officer
Sold, plan not stated
4,600
$153.50K
2.1%
REPL Replimune Group, Inc.
19 Jan 2021
Chief Business Officer
Sold, plan not stated
5,727
$243.23K
3.2%
REPL Replimune Group, Inc.
15 Jan 2021
Chief Business Officer
Sold, plan not stated
29,273
$1.28M
14.3%
REPL Replimune Group, Inc.
14 Jan 2021
Chief Business Officer
Sold, plan not stated
20,000
$900.40K
10.2%
REPL Replimune Group, Inc.
14 Oct 2020
Chief Business Officer
Sold, plan not stated
16,000
$526.41K
12.4%
REPL Replimune Group, Inc.
31 Aug 2020
Chief Business Officer
Sold, plan not stated
5,000
$135.25K
4.2%
25 decisions on file.